In drug development news, FDA granted accelerated approval for Boehringer’s Hernexeos (zongertinib) as a first-line HER2-mutant non-small cell lung cancer treatment in just 44 days, utilizing the ...

Dubai Customs has launched its Corporate Resilience Program in a strategic step that reflects the organization’s direction toward strengthening organiza ...

On Thursday the Kansas House of Representatives voted out House Bill (HB) 2434 favorably, the House’s Budget Bill for the 2026 Session. Discussion on the bill lasted one hour and thirty minutes and ...

Good day, everyone, and welcome to today's GitLab Fourth Quarter Fiscal Year 2026 Conference Call. [Operator Instructions] Please note, this call is being recorded. It is now my pleasure to turn the ...

And as we lean in further, AI is strengthening our advantage, enabling significantly more automation and value for our customers, embedding our products more deeply into their daily operations and ...

Northwood University’s University of the Aftermarket prepares future automotive aftermarket leaders through industry education and data literacy.

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

Nuvation Bio Inc. (NYSE:NUVB) Q4 2025 Earnings Call Transcript March 3, 2026 Operator: Hello, and welcome to Nuvation Bio’s Fourth Quarter and Full Year 2020 Financial Results and Corporate Update ...

UIndy Online was created in July 2024 and joined with the Sease Institute to become a new academic unit at the university, focused on developing and supporting a wide range of online, hybrid and ...

Trident Resources Corp. (TSXV: ROCK) (OTCQB: TRDTF) ("Trident" or the "Company") is pleased to announce that its Winter 2026 drilling program is being accelerated ...

The chronic kidney disease market growth is being driven by the rising global prevalence of diabetes, hypertension, and aging populations. Increasing awareness and earlier diagnosis are expanding the ...

XPEL, Inc. undertakes no obligation to publicly update or revise any forward-looking statement whether as a result of new information, future events, or otherwise. With that out of the way, I will now ...